Global COVID-19 Vaccine Acceptance Rate: Systematic Review and Meta-Analysis DOI Creative Commons
Dechasa Adare Mengistu,

Yohannes Mulugete Demu

Research Square (Research Square), Journal Year: 2022, Volume and Issue: unknown

Published: March 7, 2022

Abstract Background : A vaccine against COVID-19 is a vital tool in managing the current pandemic. It becoming evident that an effective would be required to control COVID-19. Effective use of vaccines important reducing pandemic and paving way for acceptable exit strategy. Therefore, review aimed determine global acceptance rate necessary better management Materials Methods This was conducted under Preferred Reporting Items Systematic Reviews Meta-Analysis protocols considered studies on / or hesitancy around world, written English language. Articles were searched using electronic databases including PubMed MEDLINE, Scopus /Science Direct, Web Science, Embase, CINAHL, Google Scholars. The quality study assessed Joanna Briggs Institute Critical Assessment prevalence relevance each included article study. Results pooled found 61.1% [95% CI: 53.8, 67.9% with p-value <0.001]. Based subgroup analysis by publication year, reported published 2020 2021 74.2 % 66.5, 80.7%] 47.9% 37.8, 58.2%], respectively, resulting overall 63.7% 56.8, 69.5%]. survey period, from March May [80.0% (95% 68.8, 87.9%)], June August [58.6% 38.0, 76.6%)] September December [46.3% 37.4, 55.8%)]. Conclusions decreasing level vaccine. finding indicated even if developed, issue accepting taking developed may difficult.

Language: Английский

A Global Map of COVID-19 Vaccine Acceptance Rates per Country: An Updated Concise Narrative Review DOI Creative Commons
Malik Sallam, Mariam Alsanafi, Mohammed Sallam

et al.

Journal of Multidisciplinary Healthcare, Journal Year: 2022, Volume and Issue: Volume 15, P. 21 - 45

Published: Jan. 1, 2022

Abstract: The delay or refusal of vaccination, which defines vaccine hesitancy, is a major challenge to successful control COVID-19 epidemic. huge number publications addressing hesitancy necessitates periodic review provide concise summary acceptance rates worldwide. In the current narrative review, data on were retrieved from surveys in 114 countries/territories. East and Southern Africa (n = 9), highest rate was reported Ethiopia (92%), while lowest Zimbabwe (50%). West/Central 13), Niger (93%), Cameroon (15%). Asia Pacific 16), Nepal Vietnam (97%), Hong Kong (42%). Eastern Europe/Central 7), Montenegro (69%) Kazakhstan (64%), Russia (30%). Latin America Caribbean 20), Mexico (88%), Haiti (43%). Middle East/North (MENA, n 22), Tunisia Iraq (13%). Western/Central Europe North 27), Canada (91%) Norway (89%), Cyprus Portugal (35%). ≥ 60% seen 72/114 countries/territories, compared 42 countries/territories with between 13% 59%. phenomenon appeared more pronounced MENA, Central Asia, Africa. More studies are recommended Africa, address intentions general public get vaccination. Keywords: SARS-CoV-2, hesitance, resistance, rejection, willingness vaccinate, intention vaccinate

Language: Английский

Citations

209

Systematic Review and Meta-Analysis of COVID-19 Vaccination Acceptance DOI Creative Commons
Mohd Noor Norhayati, Ruhana Che Yusof,

Yacob Mohd Azman

et al.

Frontiers in Medicine, Journal Year: 2022, Volume and Issue: 8

Published: Jan. 27, 2022

Introduction Vaccination is an essential intervention to curb the coronavirus disease 2019 (COVID-19) pandemic. This review aimed estimate pooled proportion of COVID-19 vaccine acceptance worldwide. Methods A systematic search MEDLINE (PubMed) database using “COVID-19,” “vaccine” and “acceptance” obtain original research articles published between 2020 July 2021. Only studies with full text that were in English included. The Joanna Briggs Institute meta-analysis was used assess data quality. performed generic inverse variance a random-effects model Review Manager software. Results total 172 across 50 countries worldwide Subgroup analyses regard acceptance, regions, population, gender, effectiveness, survey time. 61% (95% CI: 59, 64). It higher Southeast Asia, among healthcare workers, males, for vaccines 95% during first survey. Conclusion needs be increased achieve herd immunity protect population from disease. crucial enhance public awareness vaccination improve access vaccines. Systematic Registration PROSPERO 2021, identifier CRD42021268645.

Language: Английский

Citations

72

Communication inequalities and health disparities among vulnerable groups during the COVID-19 pandemic - a scoping review of qualitative and quantitative evidence DOI Creative Commons
Clara Häfliger, Nicola Diviani, Sara Rubinelli

et al.

BMC Public Health, Journal Year: 2023, Volume and Issue: 23(1)

Published: March 6, 2023

Abstract Background The COVID-19 pandemic has exacerbated health disparities in vulnerable groups (e.g., increased infection, hospitalization, and mortality rates people with lower income, education, or ethnic minorities). Communication inequalities can act as mediating factors this relationship. Understanding link is vital to prevent communication public crises. This study aims map summarize the current literature on linked (CIHD) during identify research gaps. Methods A scoping review of quantitative qualitative evidence was conducted. search followed guidelines PRISMA extension for reviews performed PubMed PsycInfo. Findings were summarized using a conceptual framework based Structural Influence Model by Viswanath et al. Results yielded 92 studies, mainly assessing low education social determinant knowledge an indicator inequalities. CIHD identified 45 studies. association insufficient inadequate preventive behavior most frequently observed. Other studies only found part link: ( n = 25) 5). In 17 neither nor found. Conclusions supports findings past Public institutions should specifically target their reduce More about needed migrant status, financial hardship, not speaking language country residence, sexual minorities, living deprived neighborhoods. Future also assess input derive specific strategies overcome

Language: Английский

Citations

42

Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China DOI Open Access
Jiahao Wang, Beibei Yuan, Xinran Lu

et al.

Human Vaccines & Immunotherapeutics, Journal Year: 2021, Volume and Issue: 17(12), P. 4873 - 4888

Published: Dec. 14, 2021

A cross-sectional field survey was conducted from November 2020 to January 2021 among 7259 participants investigate the public perception, willingness, and information sources for COVID-19 vaccination, with focus on elderly non-communicable chronic disease (NCD) population. Multiple logistic regressions were performed identify associated factors of vaccination willingness. The willingness rate accept future vaccine (79.08%) lower than that adults aged 18-59 (84.75%). multiple analysis didn't significant relationship between NCD status intention. main reasons hesitancy by were: concern safety, low infection risk, waiting seeing others getting vaccinated, effectiveness price. Their relative importance differed elderly, or without NCD. Perception importance, confidence, trust in health workers predictors intention both age groups. who perceived high risk had governments more likely vaccine. Compared 18-59, used fewer trusted traditional media family, relatives, friends recommendations. To promote uptake, campaigns require comprehensive interventions improve attitude, accessibility affordability, tailor strategies address specific concerns different population groups via their sources, especially elderly.

Language: Английский

Citations

66

The role of perceived social norms in college student vaccine hesitancy: Implications for COVID-19 prevention strategies DOI
Anna E. Jaffe, Scott Graupensperger, Jessica A. Blayney

et al.

Vaccine, Journal Year: 2022, Volume and Issue: 40(12), P. 1888 - 1895

Published: Jan. 26, 2022

Language: Английский

Citations

49

Willingness to receive COVID-19 vaccination among adults with chronic diseases in the Kingdom of Saudi Arabia DOI Creative Commons
Mohammed Khaled Al‐Hanawi, Kabir Ahmad, Rezwanul Haque

et al.

Journal of Infection and Public Health, Journal Year: 2021, Volume and Issue: 14(10), P. 1489 - 1496

Published: Aug. 13, 2021

People with chronic conditions such as cancer, kidney disease, lung diabetes, dementia, obesity, and heart are at elevated risk of developing severe complications, thus greater death due to COVID-19. The COVID-19 vaccine is an effective measure manage the pandemic it prevents illness death. Nevertheless, many people hesitant receive fear its side effects. aim this study was identify protective factors accepting vaccination among Saudi Arabian diseases. This extracted data from online cross-sectional self-reported questionnaire conducted on acceptability a in Arabia December 2020. included sample 521 adults who that they had Multivariable regression analyses were employed associated Arabia. estimates adjusted for confounding variables, including socio-demographic factors. Among sampled participants diseases, approximately 52% indicated willing accept vaccine. Participants higher willingness if received seasonal influenza past [odds ratio (OR): 2.179; 95% confidence interval (CI): 1.222–3.888], reported high or very levels concern about contracting (OR: 2.426; CI: 1.209–4.867), believed mandatory 84.848; 37.651–191.207). lower be vaccinated history refusal 0.211; 0.088–0.504). factors, being male 2.153; 1.007–4.603), having postgraduate degree 2.408; 0.985–5.886), unemployed 2.780; 0.876–8.827) increased receiving findings demonstrate low. Therefore, further policy measures required COVID-19–related infections toll.

Language: Английский

Citations

41

COVID-19 Vaccine Hesitancy in Italy: Predictors of Acceptance, Fence Sitting and Refusal of the COVID-19 Vaccination DOI Creative Commons
Cristina Zarbo, Valentina Candini, Clarissa Ferrari

et al.

Frontiers in Public Health, Journal Year: 2022, Volume and Issue: 10

Published: April 29, 2022

Background The hesitancy in taking the COVID-19 vaccine is a global challenge. need to identify predictors of reluctance critical. Our objectives were evaluate sociodemographic, psychological, and behavioral factors, as well attitudes beliefs that influence vaccination general population Italy. Methods A total 2,015 people assessed two waves (March, April May, 2021). Participants divided into three groups: (1) individuals who accepted (“accepters”); (2) refused (“rejecters”); (3) uncertain about their toward (“fence sitters”). Group comparisons performed using ANOVA, Kruskal-Wallis test chi-square tests. strength association between groups participants' characteristics was analyzed series multinomial logistic regression models with bootstrap internal validation (one for each factor). Results “fence sitters” group, when compared others, included younger age, lower educational level, worsening economic situation previous 3 months. After controlling sociodemographic following features emerged main risk factors being (compared “accepters”): reporting levels protective behaviors, trust institutions informational sources, frequency use agreement restrictions higher conspirative mentality. Higher perceived risk, behaviors associated likelihood becoming rather than “rejecters.” Conclusions profile revealed by this study intriguing should be focus public programmes aimed at improving adherence campaign.

Language: Английский

Citations

30

Barriers to COVID-19 vaccination among medical students in Kazakhstan: development, validation, and use of a new COVID-19 Vaccine Hesitancy Scale DOI Creative Commons
Aidos Bolatov, Seísembekov Tz, Altynay Zh. Askarova

et al.

Human Vaccines & Immunotherapeutics, Journal Year: 2021, Volume and Issue: 17(12), P. 4982 - 4992

Published: Oct. 6, 2021

The purpose of this study was to identify the main barriers vaccine acceptance among medical students in Kazakhstan and develop COVID-19 Vaccine Hesitancy Scale (COV-VHS). A cross-sectional carried out at Astana Medical University (N = 888, Kazakhstan) March 2021. Only 2% participants were currently vaccinated, 22.4% showed potential for acceptance. following most important acceptance: concern about possible side effects vaccination (73%), absence sufficient evidence on effectiveness safety (57%) quality (42%), belief that immune system will cope with even without (38%), lack trust against (33%). Moreover, identified factors associated contextual influences (e.g., communication media environment, socio-demographic factors, policies, perception pharmaceutical industry), individual group personal experience vaccination, attitudes health prevention, providers, perceived risk), specific issues vaccine/vaccination choice can reduce hesitancy by 30%). developed 12-item 6-factor model COV-VHS good validity reliability. In conclusion, there a low-level Kazakhstan. Thus, an effective education policy are needed combat pandemic.

Language: Английский

Citations

34

Global COVID-19 vaccine acceptance rate: Systematic review and meta-analysis DOI Creative Commons
Dechasa Adare Mengistu, Yohannes Mulugeta Demmu, Yohanis Alemeshet Asefa

et al.

Frontiers in Public Health, Journal Year: 2022, Volume and Issue: 10

Published: Dec. 8, 2022

A vaccine against COVID-19 is a vital tool in managing the current pandemic. It becoming evident that an effective would be required to control COVID-19. Effective use of vaccines very important controlling pandemics and paving way for acceptable exit strategy. Therefore, this systematic review meta-analysis aims determine global acceptance rate necessary better management

Language: Английский

Citations

24

SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study DOI Creative Commons
Tina Ko, Claire Dendle, Ian Woolley

et al.

Human Vaccines & Immunotherapeutics, Journal Year: 2021, Volume and Issue: 17(11), P. 4048 - 4056

Published: Aug. 6, 2021

To evaluate severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine acceptance among patients with rheumatic diseases (RMD).All rheumatology attending a large suburban health network were invited to participate in an anonymized online survey. The primary outcome of interest was SARS-COV-2 acceptance.The mean (SD) age respondents (n = 641) 52.7 (15.1) years and 74.4% 474) female. Sixty-five percent willing have vaccine, while 34.4% vaccine-hesitant (unwilling or undecided). On multivariate analysis, associated smoking (OR: 2.25 [95% CI: 1.22-4.15; p .009]), history malignancy 2.51 1.19-5.26; .015]), influenza pneumococcal vaccination the preceding year 2.69 1.78-4.05; < .001]) number COVID-Safe measures practiced 1.54 1.05-2.26; .027]). Vaccine correlated positive beliefs regarding efficacy (r 0.40; .001) safety 0.36; .001). negatively concerns side-effects -0.30; vaccine-associated RMD flare -0.21; In respondents, 39.2% more likely accept if given choice which they receive 54.5% their rheumatologist recommended it. Twenty-seven on immunomodulators withhold medications 42.1% advised by rheumatologist.SARS-COV-2 hesitancy is prevalent amongst safety, efficacy, side effects flare. Clinician recommendation, communications targeting patient could facilitate acceptance.Significance Innovations patientsVaccine effectsVaccine clinician recommendation potential improve who are hesitant.

Language: Английский

Citations

32